Abstract:Background Ulcerative colitis (UC) is an inflammatory bowel disease characterized by idiopathic and recurrent mucosal inflammation [1]. The pathogenesis is multifactorial, involving genetic susceptibility, epithelial barrier defects, dysregulation of the immune response, and environmental factors. UC is a highly heterogeneous disease [2]. Despite efforts to characterize disease subgroups and predict differential outcomes in UC patients, disease heterogeneity is not adequately translated into current clinical subclassifications. Objectives This study seeks to unravel this complexity by using an integrated systems approach that classifies UC patients into different phenotypes based on the immune microenvironment, capable of providing new insights into the development of stratified therapies. Methods RNA sequencing datasets of 602 colon tissue samples from 455 patients with UC and 147 healthy controls (HC) was imported from GEO database. The microarray datasets were transformed into immune cell components by CIBERSORT, and patients were stratified by a consensus clustering algorithm. Then, the cellular characteristics of the subtypes and the overall role of specific pathways were determined by immune cell infiltration and pathway enrichment. The clinical characteristics of the different subtypes were also analyzed to clarify the characteristics of these classifications. Results Patients can be classified into two distinct immune phenotypes (Subtype A, B) based on their specific RIME, which have different cellular and pathway characteristics. (Figure A, B) The results show that Subtype A is mainly enriched in immune cells such as B cells, CD8+ T cells, CD4+ memory T cells, DC cells, macrophages, mast cells and plasma cells. Acidic granulocytes and neutrophils were more active in Subtype B. It was also significantly enriched in the peroxisome proliferator-activated receptor (PPAR) signaling pathway in Subtype B. In contrast, Subtype A showed a strong enrichment for most inflammatory pathways B cell and T cell receptor signaling, IL-17 signaling pathway, TNF, and interleukin 4 and interleukin 13 signaling pathway. (Figure 1 D, E) In addition, there was a significant difference between molecular subclassification and disease status, with Subtype A being more active in patients (69.3% of Subtype A vs.30.6% of Subtype B subtypes in 137 cases), while inactive patients, Subtype B were more prevalent (44.8% of Subtype A vs. 55.2% of Subtype B in 105 cases). (Figure 1C) Conclusion Analysis of the immune microenvironment of colonic mucosal tissue provides good insight into the pathophysiological characteristics of UC. These results can be used as a model for future studies. the response and clinical outcomes of patients with different classification need to be further investigated. References [1]Ghosh S, Shand A, Ferguson A. Ulcerative colitis. BMJ (Clinical research ed). 2000;320(7242):1119-23. [2]Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet (London, England). 2012;380(9853):1606-19. Acknowledgements: NIL. Disclosure of Interests None Declared.

P048 Deep phenotyping of the peripheral immune cell compartment in Crohn‘s Disease

P091 Single-cell metabolic phenotyping of monocytes and macrophages in Crohn’s disease

Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination Therapy

Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn’s Disease

CD177+ Neutrophils and Its Correlation with Mucosal Impairment in Patients with Inflammatory Bowel Disease

P088 Single-cell transcriptomic analysis identifies early immune disturbances in preclinical Crohn's disease

The landscape of immune dysregulation in Crohn's disease revealed through single-cell transcriptomic profiling in the ileum and colon

Mass cytometry and single-cell RNA sequencing reveal immune cell characteristics of active and inactive phases of Crohn’s disease

AB1675 DEEP PHENOTYPING OF IMMUNE MICROENVIRONMENT IN ULCERATIVE COLITIS BY INTEGRATIVE SYSTEMS ANALYSIS

Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel Disease

Identification of Immune Cell Landscape and Construction of a Novel Diagnostic Nomogram for Crohn’s Disease

Antigen-driven expansion of public clonal T cell populations in inflammatory bowel diseases

P110 Identification of the tryptophan metabolite 3-hydroxyanthranilic acid as a novel tool for the differentiation of Crohn’s disease phenotypes

Combined plasma protein and memory T cell profiling discern IBD-patient-immunotypes related to intestinal disease and treatment outcomes

Deep learning‐based image analysis reveals significant differences in the number and distribution of mucosal CD3 and γδ T cells between Crohn's disease and ulcerative colitis

Immune Cell Landscaping Reveals Distinct Immune Signatures of Inflammatory Bowel Disease.

Identification and multimodal characterization of a specialized epithelial cell type associated with Crohn's disease

Simultaneous Profiling of the Blood and Gut T and B Cell Repertoires in Crohn's Disease and Symptomatic Controls Illustrates Tissue-specific Alterations in the Immune Repertoire of Crohn's Disease Patients

P015 CITE-seq analysis revealed immune cell diversity in colonic mesenteric lymph nodes from IBD patients

DOP32 CD226+TIGITneg expression identifies pathogenic inflammatory CD4+ memory T cells in severe Crohn’s Disease patients, opening up opportunities for patient-tailored treatment strategies

Stromal-like Cells Are Found in Peripheral Blood of Inflammatory Bowel Disease Patients and Correlate with Immune Activation State